Nucendia is an integrated drug development and commercialization solutions platform bringing together specialized CRO and scientific service organizations across the United States and Asia. Through our network of companies including Primera, TCM Groups, Xihua, and strategic partners, we provide end-to-end support for pharmaceutical and biotech innovators from discovery through clinical development and commercialization.

We combine scientific depth, operational flexibility, and global execution capabilities to help emerging and established biotech and pharmaceutical companies accelerate development timelines while maintaining regulatory-ready quality standards. Our approach is centered on precision, speed, partnership, and scientific excellence.

Our integrated capabilities span:
• Drug Development & Preclinical Services
• Bioanalysis & Biomarker Testing
• Clinical Development Support
• Biostatistics & Data Management
• CMC & Analytical Development
• Regulatory & Compliance Consulting
• API Process Development & Manufacturing
• AI-Enabled Drug Development Solutions

At Nucendia, we believe drug development partners should function as an extension of their clients’ scientific and operational teams — delivering responsive collaboration, scalable execution, and global expertise from molecule to market.

Our specialties include:
• CRO Services
• Drug Development
• Bioanalysis
• Biostatistics
• Clinical Development
• CMC Development
• Regulatory Affairs
• Small Molecule Development
• Biologics Development
• Cell & Gene Therapy
• API Process Development
• Analytical Chemistry
• Clinical Data Management
• GMP Manufacturing
• Pharmaceutical Outsourcing
• AI Drug Development
• Biotech Partnerships
• IND / NDA / BLA Support
• Preclinical Research
• Global Drug Development

Nucendia

Org chart

Teams

Offices

Nucendia

Org chart

Teams

Offices

Related companies